Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
Annals of Translational Medicine|September 17, 2021
A narrative review of tumor heterogeneity and challenges to tumor drug therapyLiang Zhu, Minlin Jiang, Hao Wang, et al.
Translational Lung Cancer Research|July 18, 2020
Mechanisms of drugs-resistance in small cell lung cancer: DNA-related, RNA-related, apoptosis-related, drug accumulation and metabolism procedurePeixin Chen, Peng Kuang, Lei Wang, et al.
Journal of Healthcare Engineering|November 29, 2021
Percutaneous Microwave Coagulation Therapy: A Promising Therapeutic Method for Breaking the Barrier of the Intertumor HeterogeneityHaoyue Guo, Bin Chen, Wei Li, et al.
Annals of Translational Medicine|March 17, 2020
RNA sequencing analysis of small cell lung cancer reveals candidate chemotherapy insensitivity long noncoding RNAs and microRNAsPeng Kuang, Peixin Chen, Lei Wang, et al.
Small Methods|December 20, 2021
Mechanisms of Progression and Heterogeneity in Multiple Nodules of Lung AdenocarcinomaYayi He, Xiaogang Liu, Hao Wang, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|April 14, 2025
Unraveling tumoral heterogeneity and angiogenesis-associated mechanisms of PD-1 and LAG-3 dual inhibition in lung cancers by single-cell RNA sequencingLishu Zhao, Chen Tang, Xuan Jin, et al.
Journal for Immunotherapy of Cancer|August 7, 2021
Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I-III small cell lung cancerPeixin Chen, Lishu Zhao, Hao Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2017
LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating LymphocytesYayi He, Hui Yu, Leslie Rozeboom, et al.
Frontiers in Oncology|December 13, 2021
Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune MicroenvironmentPeixin Chen, Hao Wang, Lishu Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancerSha Zhao, Guanghui Gao, Wei Li, et al.
Pageof 16